Skip to main content

Table 2 IFNγ Specific Human Response (HR>10%) in LD Patients with EM and Healthy Individuals that were WCS Negative

From: IFNγ production in peripheral blood of early Lyme disease patients to hLFAαL (aa326-345)

  Lyme Disease patients with EM N.Pos/total (%) Healthy, WCS neg N.Pos/total (%)
  < 1 month At 3 months OspA vacc. LD total Healthy total
hLFAaL(aa326-345) 4/7 (57%) 5/9 (56%) 2/3 (67%) 11/19 (58%) 3/15 (20%)
OspAB31(aa164-183) 1/7 (14%) 1/9 (11%) 0/3 (0%) 2/19 (11%) 0/15 (0%)
  1. WCS, whole cell sonicate; LD, Lyme disease; EM, erythema migrans; hLFA, human leucocyte associated function antigen; OspA vacc., OspA vaccinated; N.Pos., number of positives